Skip to main content
Clinical Trials/JPRN-UMIN000016340
JPRN-UMIN000016340
Recruiting
未知

Comparison study for the best use of the biologic agent in rheumatoid arthritis treatment with certolizumab pegol in the real world - Beagle study

ORTHERN CAPITAL CLINIC0 sites30 target enrollmentFebruary 16, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
Rheumatoid Arthritis
Sponsor
ORTHERN CAPITAL CLINIC
Enrollment
30
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 16, 2015
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
ORTHERN CAPITAL CLINIC

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Subjects who are inadequate for the treatment with certolizumab pegol according to the attached document of the drug must be excluded from participation in this study.

Outcomes

Primary Outcomes

Not specified

Similar Trials